Click here and sign up now
New year, new rules. So, what does 2023 have in store for pharma R&D?
Growing miniature organs in a lab may have been a staple of science fiction, but with the rise of organoids and organ chips, the concept is quickly becoming science fact in drug R&D
From table-climbing bulldogs to how team sports helped to prepare her for a CEO role, Dr Michelle Longmire gives us a behind-the-scenes glimpse of her work and world
In this interactive webinar, sponsored by IQVIA, experts will explore the critical role of mutually beneficial partnerships between the pharmaceutical industry and the NHS
IBD affects millions of patients around the world, but Verily’s Dr Amy Abernethy believes a holistic approach to data collection could help to unlock the secrets of these conditions
Addressing pharma’s clinical trial diversity problem is a complex challenge. pharmaphorum editor-in-chief Jonah Comstock spoke with experts from across the industry who are doing the work to learn what it will take to make real progress
Download exclusive interviews and discussions with senior pharma and biotech executives
pharmaphorum editor-in-chief Jonah Comstock discusses key trends in cancer R&D with SVP and head of oncology at AstraZeneca, Mohit Manrao
In an upcoming event, experts from Healthware International, Grünenthal Group, and EVERSANA INTOUCH will explore how to move beyond the digital native myth towards true digital enlightenment
To learn more about this year’s key challenges and opportunities, Deep Dive went straight to the experts to ask: What are the biggest pharma R&D trends to watch in 2023?
Keep up to date with important industry events taking place across the pharmaceutical industry with this interactive guide to upcoming conferences around the world
Sign-up to receive the next issue of pharmaphorum’s digital magazine for pharma direct to your inbox
E-mail address receiver
Thank you for your feedback.